Should People Know About the Results of Their Genome Screening?
By Kim Carollo,
ABC News
| 02. 03. 2012
If you were at higher risk for developing a condition like Alzheimer's disease or breast cancer, would you want to know about it?
With rapid advances in genome sequencing, researchers are learning more about people's susceptibility to certain diseases, and a host of ethical questions about whether people are entitled to information yielded by their genes are causing scientists concern.
In order to help answer this question, a British research institute introduced a new online survey designed to gauge people's opinions, asking questions such as whether relevant findings from genome studies should be shared with research participants and whether other information uncovered during analysis should also be shared.
A team of ethicists from the Wellcome Trust Sanger Institute developed the tool because of a disagreement with the current practice of keeping findings anonymous and not revealing information that could impact people's health later, according to a press release.
"Although the scientists might be trying to find the genetic basis of one disease, e.g. breast cancer, by virtue of looking across all genes in one go, they might uncover...
Related Articles
By Staff, GMWatch | 03.28.2026
Following a recent podcast interview we were asked whether there is any solid scientific research looking at how gene expression or molecular composition in genetically modified (GM) plants differs from conventionally bred plants. As this is an interesting and important...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Rowan Walrath and Laurel Oldach, Chemical & Engineering News | 03.04.2026
Washington, DC—At a press conference held at the US Department of Health and Human Services headquarters on Feb. 23, two doctors from the University of Pennsylvania and Children’s Hospital of Philadelphia spoke about their hope for the future of...